ArticleJournal of family medicine and primary care2019
Beneficial effects of gluten free diet on IgA tissue transglutaminase levels and various growth parameters in celiac disease patients.
Article in Journal of family medicine and primary care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 7 citations in OpenAlex.
- Changes in the anthropometric measurements in children and adolescents with coeliac disease over a two-year follow-up.European journal of pediatrics · 2025Observational
- Clinical presentations and outcomes of celiac disease in children and adolescents at a tertiary care center in Lebanon.Frontiers in pediatrics · 2025Article
- Celiac disease - a pluripathological model in pediatric practice.Frontiers in immunology · 2024Review
- Personalised Nutritional Plan and Resistance Exercise Program to Improve Health Parameters in Celiac Women.Foods (Basel, Switzerland) · 2022Article
- Study of effect of gluten-free diet on vitamin D levels and bone mineral density in celiac disease patients.Journal of family medicine and primary care · 2022Article
- Incidence of celiac disease autoimmunity and associations with maternal tuberculosis and pediatricFrontiers in pediatrics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextIn the resource poor country like India it is difficult to get HLA screening and EMA testing in patients with celiac disease in small centres.
aimsTo study the effect of gluten free diet on IgA tissue transglutaminase levels and various growth parameters in patients with celiac disease. SETTINGS AND
designThis was a prospective study conducted in the department of paediatrics of a tertiary referral hospital in north India in 3 stages viz. on presentation, after 3 months and 6 months of initial presentation. MATERIALS AND
methods392 patients with symptoms suggestive of celiac disease were screened for IgA tTG levels more than 10 folds of upper limit of normal. 50 cases (who followed up for 6 months regularly) were enrolled in the study. Spectrum of various growth and clinical parameters were also studied. Statistical analysis used: Statistical analysis was performed by the SPSS version 20.0. Data were checked for normality before statistical analysis. p value less than 0.05 was considered statistically significant.
results50 cases were enrolled in study. After initiation of gluten free diet, improvements were seen in various growth factors like height (12.71%) and weight (3.47 cm) after 6 months. Serum tTG(IgA) levels decreased to 94.88±55.35 U/mL from baseline level of 202±83.96 U/mL after 6 months.
conclusionsGluten free diet has major role in improvement in growth parameters as well as anemia. So, early detection of celiac disease is an important step in prevention of morbidity associated with this chronic disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.